39th Street OverpassDoug with a dog in the labScott Weir at the 2015 Golden Ribbon Youth Soccer Tournament

IAMI partners with BioNovus to develop bladder cancer drug

IAMI and BioNovus join to speed biotech, pharma commercialization on bladder cancer drug. Read More

Project Aims to Introduce New Cancer Drugs to Market

Researchers at the University of Kansas Medical Center are hoping that a new project can bring two new cancer drugs to market - one for humans and another for their furry friends. Read More

Golden Ribbon Youth Soccer Tournament

IAMI Director Dr. Scott Weir accepting a $6,000 check from the proceeds of the Inaugural Gold Ribbon Youth Soccer Tournament held October 24, 2015. The funds will be used to support IAMI’s pediatric sarcoma research. Learn more

Institute for Advancing Medical Innovation

The Institute for Advancing Medical Innovation (IAMI) serves as a national model for philanthropy, industry and universities to collaborate in advancing university innovations in life sciences by:

Vision Change the standard of care for pediatric, adolescent and adult patients living with diseases including cancer and rare diseases.

Mission Discover and develop pharmaceuticals and diagnostics with a clear path to market.

Core Hypothesis The investment in high potential academic projects with industry-experienced leadership will enhance the yield of commercial products that benefit patients.

Photo of children
Children's Mercy Kansas City
Together, IAMI and Children's Mercy Kansas City have advanced several discoveries to patient treatments.

Frontiers logo
Frontiers Heartland Institute
IAMI and Frontiers accelerate the process of lab discoveries becoming patient treatments.
researchers in a lab
KU Cancer Center
Innovation and discovery drive the partnership between The University of Kansas Cancer Center and IAMI.

KU Endowment Building
KU Endowment
KU Endowment financially supports IAMI to bring new drugs and treatments to the market.
Last modified: Feb 16, 2016
About Us

IAMI is based on strong leadership, which includes:

• External advisory board of national and international experts

• Internal leadership of experts from drug development and medical device industries, foundations, and academic institutions

• Network of alumni and biotechnology professionals supporting the mission through expertise and passion